FWM
ROIV icon

Forefront Wealth Management’s Roivant Sciences ROIV Stock Holding History

Forefront Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$209K Buy
+9,622
New +$190K 0.15% 65

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Forefront Wealth Management's ROIV Position: Q4 2025 in Review

Forefront Wealth Management opened a new position in Roivant Sciences (ROIV) in Q4 2025: 9,622 shares worth $209K. The stake represents 0.15% of the portfolio and ranks #65 among its holdings.

396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Forefront Wealth Management held 9,622 shares of Roivant Sciences worth $209K as of Q4 2025.
  • Roivant Sciences was a new Forefront Wealth Management position in Q4 2025.
  • Roivant Sciences made up 0.15% of Forefront Wealth Management's portfolio in Q4 2025, its #65 holding.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Forefront Wealth Management's 13F filing for Q4 2025, filed 23 Jan 2026.